COVID shots should target JN.1 variant in 2024-25 campaign, US FDA says
The U.S. Food and Drug Administration on Friday advised COVID-19 vaccine manufacturers that new shots for the fall 2024 campaign should target the JN.1 variant that was dominant earlier this year. The FDA's advisory is in line with European and World Health Organization recommendations and comes after the U.